Fundraising Fox
/Companies
Sign in

Accure Therapeutics

5 known investors

Find your way into Accure Therapeutics

Each arrow is one introduction. Sign up to fill in the first one.

1,138 people can intro you to Pablo

Ask Anna Bellmunt to introduce you to Pablo Villoslada

You →Anna · together at Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) →Pablo

172 people can intro you to Paul

Ask Jamie Chen to introduce you to Paul Bikard

You →Jamie · together at Sensorion →Paul

119 people can intro you to Laurent

Ask Sam Okafor to introduce you to Laurent Nguyen

You →Sam · together at Bionure →Laurent

Sign up to find every way you can get introduced to Accure Therapeutics

  • Your email: who you already know at Accure Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Accure Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases. It operates in the biotech sector.

BiotechHealthtech

Founders & leadership

LNLaurent Nguyen
Laurent NguyenCEOLaurent Nguyen is CEO of Accure Health, a biotech company developing CNS disease treatments. He brings experience across pharmaceutical development, commercialization, and business development, including prior roles in pharma marketing, sales, acquisitions, and medical practice.
PVPablo Villoslada
Pablo VillosladaCSOPablo Villoslada is a neurologist with over 20 years of experience in translational medicine across academia, biotech, medical devices, and pharmaceutical settings, with expertise spanning drug development (small molecules and cell therapy), clinical trial design and execution through Phase III, regulatory submissions, medical devices including neurostimulation, and digital health applications.
RMRossella Medori
Rossella MedoriCMOCMO at Accure
PBPaul Bikard
Paul BikardCFOPaul Bikard is CFO of Accure Health, a biotech company developing CNS disease treatments. He has CFO experience in the biotechnology industry across companies of various stages.

Investors · 5

Asabys Partnerslisted by Asabys PartnersBarcelona

How we know: Asabys Partners's portfolio page · the VCSheet dataset · Not right? Tell us

Kinled Holdinglisted by Kinled HoldingHong Kongvia Patrick Aisher · inferred
Lifelinklisted by LifelinkBarcelona

How we know: Lifelink's portfolio page · Not right? Tell us

Alta Life SciencesreportedBarcelona

How we know: a partner's Signal profile · Not right? Tell us

Related companies · 5

RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Acurx PharmaceuticalsAcurx Pharmaceuticals is a clinical-stage biopharmaceutical company developing a new class of antibiotics targeting bacterial infections classified as priority pathogens by the WHO, CDC, and FDA. It is a publicly held company focused on antibiotic drug development.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

Companies working in the same space as Accure Therapeutics.

Frequently asked questions

What does Accure Therapeutics do?
Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases. It operates in the biotech sector.
Who are Accure Therapeutics's investors?
Accure Therapeutics's investors include Aliath Bioventures, Asabys Partners, Kinled Holding, Lifelink, Alta Life Sciences.